The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Gold nanoparticle–conjugated quercetin inhibits epithelial–mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR‐2‐mediated pathway in breast cancer
Open accessAbstract
Objectives: Epidermal growth factor plays a critical role in breast malignancies by enhancing cell proliferation, invasion, angiogenesis and metastasis. Epithelial–mesenchymal transition (EMT) is a crucial process by which epithelial cells lose polarity and acquire migratory mesenchymal properties. Gold nanoparticles are an efficient drug delivery vehicle for carrying chemotherapeutic agents to target cancer cells and quercetin is an anti‐oxidative flavonoid known with potent anti‐malignant cell activity. Materials and methods: Cell viability was assessed by MTT assay, and protein expression was examined by Western blotting and immunocytochemistry. Cell invasion was monitored using invasion chambers, and cell migration was analysed by scratch wound‐healing assay. In vitro and ex vivo angiogenesis studies were performed by capillary‐like tube formation assay and chick embryo angiogenesis assay (CEA). 7,12‐dimethylbenz(a)anthracene (DMBA) induced mammary carcinoma in Sprague‐Dawley rats. Results: We observed a significant reduction in protein expression of vimentin, N‐cadherin, Snail, Slug, Twist, MMP‐2, MMP‐9, p‐EGFR, VEGFR‐2, p‐PI 3K, Akt and p‐GSK 3β, and enhanced E‐cadherin protein expression in response to Au NP s‐Qu‐5 treatment. Au NP s‐Qu‐5 inhibited migration and invasion of MCF‐7 and MDA‐MB‐231 cells compared to free quercetin. Au NP s‐Qu‐5‐treated HUVEC s had reduced cell viability and capillary‐like tube formation. In vitro and in vivo angiogenesis assays showed that Au NP s‐Qu‐5 suppressed tube and new blood vessel formation. Treatment with Au NP s‐Qu‐5 impeded tumour growth in DMBA‐induced mammary carcinoma in SD rats compared to treatment with free quercetin. Conclusion: Our results suggest that Au NP s‐Qu‐5 inhibited EMT, angiogenesis and metastasis of the breast cancer cells tested by targeting the EGFR/VEGFR‐2 signalling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
Breast cancer metastasis: markers and models
Weigelt, B., Peterse, J. L., & van't Veer, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1670 · Cited by 2,232
Cited by
The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis
Ghasemi, M., Turnbull, T., Sebastian, S., & Kempson, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312827 · Cited by 1,333
Anticancer potential of quercetin: A comprehensive review
Rauf, A., Imran, M., Khan, I. A., ur‐Rehman, M., Gilani, S. A., Mehmood, Z., & Mubarak, M. S. (2018) · Phytotherapy Research · doi:10.1002/ptr.6155 · Cited by 654
Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects
Tang, S.-M., Deng, X.-T., Zhou, J., Li, Q.-P., Ge, X.-X., & Miao, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109604 · Cited by 654
Gold Nanoparticles in Cancer Treatment
Sztandera, K., Gorzkiewicz, M., & Klajnert-Maculewicz, B. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00810 · Cited by 607
Xie, X., Liao, J., Shao, X., Li, Q., & Lin, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-04229-z · Cited by 462
Burlec, A. F., Corciova, A., Boev, M., Batir-Marin, D., Mircea, C., Cioanca, O., Danila, G., Danila, M., Bucur, A. F., & Hancianu, M. (2023) · Pharmaceuticals · doi:10.3390/ph16101410 · Cited by 295
Nanoparticle-mediated targeted drug delivery for breast cancer treatment
Liyanage, P. Y., Hettiarachchi, S. D., Zhou, Y., Ouhtit, A., Seven, E. S., Oztan, C. Y., Celik, E., & Leblanc, R. M. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.006 · Cited by 287
Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential
Kashyap, D., Garg, V. K., Tuli, H. S., Yerer, M. B., Sak, K., Sharma, A. K., Kumar, M., Aggarwal, V., & Sandhu, S. S. (2019) · Biomolecules · doi:10.3390/biom9050174 · Cited by 285
Nanoparticle mediated alteration of EMT dynamics: an approach to modulate cancer therapeutics
Sen, P., Saha, M., & Ghosh, S. S. (2020) · Materials Advances · doi:10.1039/d0ma00455c · Cited by 21
Metadata
- Authors
- Balakrishnan, S., Bhat, F. A., Raja Singh, P., Mukherjee, S., Elumalai, P., Das, S., Patra, C. R., & Arunakaran, J.
- Venue
- Cell Proliferation
- Publisher
- Wiley
- Published
- 2016-09-18
- Volume
- 49
- Issue
- 6
- Pages
- 678-697
- ISSN
- 0960-7722 (ISSN-L)
- 1365-2184
- OpenAlex
- W2461689898
- Cited by
- 239
- References
- 4
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.